AI
Tuesday, September 13, 2016 10:11:50 AM
Jeff Hutchins(VP/PreClin.Res) today at NEO-SYNTH's Lung Cancer Summit/Boston
Sept13-14 2016: “NEO-SYNTH's Precision: Lung Cancer - World R&D Summit”, Boston
“Precision: Lung Cancer will bring together scientists & business leaders from pharma, biotech and academia, using extensive networking sessions to forge meaningful collaborations.”
http://precisionlungcancer.com
NEO-SYNTH: “Connecting The Pharma Industry By Forging Interactions” http://neo-synth.com
Agenda 9-13-16: http://precisionlungcancer.com/agenda--day-one.html
Agenda 9-14-16: http://precisionlungcancer.com/agenda--day-two.html
9-13-16 4:30pm: Speaker: Jeff Hutchins (VP/Prelin.Res., Peregrine), “Overriding Immune Suppression and Increasing TILs Through Blockade of the Phosphatidylserine Signaling Pathway”
= = = = = = = = = =KNOWN UPCOMING:
Sep13: NEO-SYNTH's "Precision: Lung Cancer - World R&D Summit", Boston http://tinyurl.com/hq9m8ej
...4:30pm: Dr. Jeff Hutchins(VP/PreClin.Res), ”Overriding Immune Suppression & Increasing TILs Through Blockade of the PS-Signaling Pathway”
Sep15: EXL's 11th Medical Affairs Executive Forum, SanDiego http://exlevents.com/medical-affairs-executive-forum-west
...11:15–12pm: Dr. Lisa Stepp, PPHM's PhD/Sen.Dir./MedAffairs, ”Effects of Co. Size on the Est. of an Advisory Board Benchmark”
Sep22: Phacilitate’s "Immunotherapy Europe" (Strategic Partnering Event), Berlin http://tinyurl.com/hwxax88
...9:50-10:20am WEBINAR - Steve King is Panelist w/BMS/Merck/Agenus: “Analyzing The Business & Partnering Model in Industry & Academia for the Future Dev. of I-O Combination Therapies”
Sep25-28: 2nd AACR-CRI Intl. Cancer Immunotherapy Conf.”, NYC http://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=101
...”Exciting” internal preclin. work related to the MSK-Collab to be presented” (per 9-8-16/CCall/Hutchins)
Oct4-7/Avid/Booth#716: IBC's BioProcess Intl. Conf., Boston http://www.ibclifesciences.com/BPI/overview.xml & http://tinyurl.com/zyblds7
...10-5-16/8-8:30am: Peter Gagnon (Avid's VP/Process-Svcs), “Across the Great Divide: The Upstream Origins & Downstream Ramifications of a Newly Discovered Contaminant Class”
Oct7-11: 41th ESMO European Cancer Congress, Copenhagen, Denmark http://tinyurl.com/j2cng2y
...”Oral Presentation of Top-line data from the Ph3 SUNRISE trial” (per 9-8-16/PR)
...10-10-16 9:15-9:30am: Dr. David Gerber(UTSW) Proffered Oral Presentation, “Top-line Results from Ph3/SUNRISE... (incl. “initial results from ongoing biomarker analysis”)
...10-9-16 1:00-2:00pm: Jeff Hutchins(VP/PreClin.Res), “Antibody Mediated Blockade of PS Improves Immune Checkpoint Blockade...”
Oct13/10am: Annual SHM, Avenue of the Arts Hotel, Costa Mesa – Final Proxy: http://tinyurl.com/gsrmgs2
Nov9-13: (SITC) Society for Immunotherapy of Cancer 31st Annual Meeting”, Natl-Harbor MD http://www.sitcancer.org/2016
...”First Results” from our collaboration with Jedd Wolchok Lab investigators (MSK) to be presented” (per 9-8-16/Ccall/Hutchins)
~Dec8: FY'17Q2 (qe 10-31-16) Financials & Conf. Call - http://ir.peregrineinc.com/events.cfm
Dec11-15/Avid/Booth#209: IBC's Antibody Eng. & Therapeutics 2016”, SanDiego http://www.ibclifesciences.com/AntibodyEng/overview.xml
Sept13-14 2016: “NEO-SYNTH's Precision: Lung Cancer - World R&D Summit”, Boston
“Precision: Lung Cancer will bring together scientists & business leaders from pharma, biotech and academia, using extensive networking sessions to forge meaningful collaborations.”
http://precisionlungcancer.com
NEO-SYNTH: “Connecting The Pharma Industry By Forging Interactions” http://neo-synth.com
Agenda 9-13-16: http://precisionlungcancer.com/agenda--day-one.html
Agenda 9-14-16: http://precisionlungcancer.com/agenda--day-two.html
9-13-16 4:30pm: Speaker: Jeff Hutchins (VP/Prelin.Res., Peregrine), “Overriding Immune Suppression and Increasing TILs Through Blockade of the Phosphatidylserine Signaling Pathway”
= = = = = = = = = =KNOWN UPCOMING:
Sep13: NEO-SYNTH's "Precision: Lung Cancer - World R&D Summit", Boston http://tinyurl.com/hq9m8ej
...4:30pm: Dr. Jeff Hutchins(VP/PreClin.Res), ”Overriding Immune Suppression & Increasing TILs Through Blockade of the PS-Signaling Pathway”
Sep15: EXL's 11th Medical Affairs Executive Forum, SanDiego http://exlevents.com/medical-affairs-executive-forum-west
...11:15–12pm: Dr. Lisa Stepp, PPHM's PhD/Sen.Dir./MedAffairs, ”Effects of Co. Size on the Est. of an Advisory Board Benchmark”
Sep22: Phacilitate’s "Immunotherapy Europe" (Strategic Partnering Event), Berlin http://tinyurl.com/hwxax88
...9:50-10:20am WEBINAR - Steve King is Panelist w/BMS/Merck/Agenus: “Analyzing The Business & Partnering Model in Industry & Academia for the Future Dev. of I-O Combination Therapies”
Sep25-28: 2nd AACR-CRI Intl. Cancer Immunotherapy Conf.”, NYC http://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=101
...”Exciting” internal preclin. work related to the MSK-Collab to be presented” (per 9-8-16/CCall/Hutchins)
Oct4-7/Avid/Booth#716: IBC's BioProcess Intl. Conf., Boston http://www.ibclifesciences.com/BPI/overview.xml & http://tinyurl.com/zyblds7
...10-5-16/8-8:30am: Peter Gagnon (Avid's VP/Process-Svcs), “Across the Great Divide: The Upstream Origins & Downstream Ramifications of a Newly Discovered Contaminant Class”
Oct7-11: 41th ESMO European Cancer Congress, Copenhagen, Denmark http://tinyurl.com/j2cng2y
...”Oral Presentation of Top-line data from the Ph3 SUNRISE trial” (per 9-8-16/PR)
...10-10-16 9:15-9:30am: Dr. David Gerber(UTSW) Proffered Oral Presentation, “Top-line Results from Ph3/SUNRISE... (incl. “initial results from ongoing biomarker analysis”)
...10-9-16 1:00-2:00pm: Jeff Hutchins(VP/PreClin.Res), “Antibody Mediated Blockade of PS Improves Immune Checkpoint Blockade...”
Oct13/10am: Annual SHM, Avenue of the Arts Hotel, Costa Mesa – Final Proxy: http://tinyurl.com/gsrmgs2
Nov9-13: (SITC) Society for Immunotherapy of Cancer 31st Annual Meeting”, Natl-Harbor MD http://www.sitcancer.org/2016
...”First Results” from our collaboration with Jedd Wolchok Lab investigators (MSK) to be presented” (per 9-8-16/Ccall/Hutchins)
~Dec8: FY'17Q2 (qe 10-31-16) Financials & Conf. Call - http://ir.peregrineinc.com/events.cfm
Dec11-15/Avid/Booth#209: IBC's Antibody Eng. & Therapeutics 2016”, SanDiego http://www.ibclifesciences.com/AntibodyEng/overview.xml
